LeonaBio, Inc. Basic Shares Outstanding (Weighted Average)
LeonaBio, Inc. (LONA) reported Basic Shares Outstanding (Weighted Average) of 23.73 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- LeonaBio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 23.73M shares, a 506.92% increase year-over-year.
- LeonaBio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 19.03M shares, a 387.34% increase year-over-year.
- LeonaBio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 5.35M shares, a 38.11% increase year-over-year.
- LeonaBio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 3.94M shares, a 2.39% increase year-over-year.
- LeonaBio, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 4.28M shares, a 11.12% increase from fiscal 2024.
- LeonaBio, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 3.85M shares, a 89.88% decline from fiscal 2023.
- LeonaBio, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 38.02M shares, a 0.76% increase from fiscal 2022.
- LeonaBio, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 37.73M shares, a 2.20% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 23.73M shares 10-Q · filed 2026-08-14 | 21.39M shares 10-Q · filed 2026-08-14 | 16.03M shares derived: average of 3 quarters · filed 2026-08-14 | 13.01M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 19.03M shares 10-Q · filed 2026-05-07 | 12.19M shares derived: average of 2 quarters · filed 2026-05-07 | 9.44M shares derived: average of 3 quarters · filed 2026-05-07 | 8.06M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 5.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 4.64M shares derived: average of 2 quarters · filed 2026-03-31 | 4.40M shares derived: average of 3 quarters · filed 2026-08-14 | 4.28M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 3.94M shares 10-Q · filed 2025-11-06 | 3.93M shares derived: average of 2 quarters · filed 2026-08-14 | 3.92M shares 10-Q · filed 2025-11-06 | 3.91M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 3.91M shares 10-Q · filed 2026-08-14 | 39.09M shares 10-Q · filed 2025-08-07 | 3.93M shares 10-Q · filed 2026-08-14 | 39.07M shares 10-Q · filed 2025-08-07 | 3.89M shares derived: average of 3 quarters · filed 2026-08-14 | 3.88M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | 3.90M shares 10-Q · filed 2026-05-07 | 39.04M shares 10-Q · filed 2025-05-09 | 3.89M shares derived: average of 2 quarters · filed 2026-05-07 | 3.88M shares derived: average of 3 quarters · filed 2026-05-07 | 12.50M shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | 3.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 3.86M shares derived: average of 2 quarters · filed 2026-03-31 | 15.37M shares derived: average of 3 quarters · filed 2026-03-31 | 3.85M shares 10-K · filed 2026-03-31 | 38.48M shares 10-K · filed 2025-02-27 | |||
| 2024-09-30 | 3.85M shares 10-Q · filed 2025-11-06 | 38.52M shares 10-Q · filed 2024-11-07 | 21.12M shares derived: average of 2 quarters · filed 2025-11-06 | 3.84M shares 10-Q · filed 2025-11-06 | 38.41M shares 10-Q · filed 2024-11-07 | 29.66M shares derived: average of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | 38.38M shares 10-Q · filed 2025-08-07 | 38.35M shares 10-Q · filed 2025-08-07 | 38.35M shares 10-Q · filed 2024-08-01 | 38.27M shares derived: average of 3 quarters · filed 2025-08-07 | 38.21M shares derived: average of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | 38.32M shares 10-Q · filed 2025-05-09 | 38.21M shares derived: average of 2 quarters · filed 2025-05-09 | 38.16M shares derived: average of 3 quarters · filed 2025-05-09 | 38.12M shares derived: average of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | 38.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 38.08M shares derived: average of 2 quarters · filed 2025-02-27 | 38.05M shares derived: average of 3 quarters · filed 2025-02-27 | 38.02M shares 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | 38.05M shares 10-Q · filed 2024-11-07 | 38.03M shares derived: average of 2 quarters · filed 2024-11-07 | 37.99M shares 10-Q · filed 2024-11-07 | 37.96M shares derived: average of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | 38.00M shares 10-Q · filed 2024-08-01 | 37.96M shares 10-Q · filed 2024-08-01 | 37.92M shares derived: average of 3 quarters · filed 2024-08-01 | 37.90M shares derived: average of 4 quarters · filed 2024-08-01 | ||||
| 2023-03-31 | 37.92M shares 10-Q · filed 2024-05-15 | 37.89M shares derived: average of 2 quarters · filed 2024-05-15 | 37.86M shares derived: average of 3 quarters · filed 2024-05-15 | 37.82M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 37.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 37.83M shares derived: average of 2 quarters · filed 2024-02-22 | 37.78M shares derived: average of 3 quarters · filed 2024-02-22 | 37.73M shares 10-K · filed 2024-02-22 | ||||
| 2022-09-30 | 37.82M shares 10-Q · filed 2023-11-09 | 37.74M shares derived: average of 2 quarters · filed 2023-11-09 | 37.69M shares 10-Q · filed 2023-11-09 | 37.61M shares derived: average of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | 37.67M shares 10-Q · filed 2023-08-10 | 37.63M shares 10-Q · filed 2023-08-10 | 37.54M shares derived: average of 3 quarters · filed 2023-08-10 | 37.48M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 37.59M shares 10-Q · filed 2023-05-11 | 37.48M shares derived: average of 2 quarters · filed 2023-05-11 | 37.42M shares derived: average of 3 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | 37.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 37.34M shares derived: average of 2 quarters · filed 2023-03-23 | 36.92M shares 10-K · filed 2023-03-23 | |||||
| 2021-09-30 | 37.31M shares 10-Q · filed 2022-11-10 | 36.77M shares 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |